Paige Reviews

Athena Security delivers an industry-leading, AI-powered concealed weapons detection system and entryway security platform for hospitals, K–12 schools, casinos, places of worship, government buildings, and other high-traffic environments where speed, accuracy, and safety are critical. The Apollo 500 concealed weapons detection system enables seamless walk-through screening, using advanced AI to accurately distinguish real threats such as firearms and knives from everyday items like phones and keys—maximizing throughput while reducing false alarms. Athena’s AI-powered baggage X-ray scanner modernizes screening with Apple iPad-based control, replacing legacy consoles with an intuitive interface that improves usability, reduces training time, enables remote operation, and enhances threat detection through automated identification of suspicious items. Athena’s Hospital Visitor Management System delivers deeper intelligence than traditional systems, including visitor history, prior incidents, and person-of-interest alerts—empowering faster, more informed decisions. Integration with EPIC strengthens healthcare workflows while maintaining high security standards. First-of-its-kind innovations include the Ambulance Bay Weapons Detection System (AB-WDS) purpose built for hopsitals for screening stretcher patients and a secondary screening solution for feet and bags, reducing human error in courthouses and government facilities. Built for compliance and real-world deployment across U.S. regions, Athena aligns with DHS best practices and evolving state regulations, including healthcare security mandates AB2975. Telepresence and AR alert glasses provide real-time operational support, while all systems unify into one platform for centralized monitoring, analytics, and enterprise reporting.

QBench provides a comprehensive solution for monitoring all your samples and their positions within the workflow through a unified platform. By using QBench, you can forgo the traditional reliance on spreadsheets, shared network folders, and outdated paper tracking systems. The platform enables you to review numerous PDF reports and Certificates of Analysis (COAs) before finalizing or distributing them via email. You also have the option to create customizable barcodes and labels for your samples, ensuring compatibility with standard printers and scanners. Additionally, QBench features a billing module that streamlines the creation and dispatch of invoices directly from the system. Users can access data on counts and latencies for various data types within QBench, which encompasses metrics such as turnaround times, sample counts per test, delays, and more. This innovative tool simplifies the data collection process necessary for the assays conducted in your laboratory while enhancing overall efficiency. With QBench, managing your laboratory workflow has never been more straightforward and effective.

Ibex Medical Analytics leads the way in the application of AI technology for cancer diagnostics within pathology. Our multidisciplinary team consists of entrepreneurs, software engineers, data scientists, and healthcare professionals who share a common goal: to transform cancer diagnostics through artificial intelligence, ultimately improving the quality of patient care. As the number of tests conducted each year increases, pathologists encounter considerable challenges in providing accurate and timely evaluations. To tackle these issues, Ibex utilizes AI to develop clinical-grade solutions designed to detect cancer with a level of precision comparable to that of human pathologists. The Galen Platform uses sophisticated algorithms to analyze imaging, identify and categorize cancer in biopsy samples, and emphasize other clinically relevant findings, which aids pathologists in reducing diagnostic mistakes and enhancing their workflow efficiency. In particular, Ibex's Galen™ Prostate and Galen™ Breast tools are groundbreaking AI-driven cancer detection solutions that have been integrated into standard clinical practice in pathology laboratories, demonstrating proven effectiveness in identifying cancer cases that were previously overlooked. As we persist in our quest for progress, our dedication to advancing cancer detection and improving patient outcomes continues to be resolute and inspiring for the entire medical community.